PDF icon Download PDF
J Knee Surg
DOI: 10.1055/a-2693-0702
Original Article

Comparable PROM Gains and Satisfaction After TKA in Medicare Advantage vs. Traditional Medicare: A Multivariable Analysis of 6,010 Patients

Benjamin E. Jevnikar
1   Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, Ohio, United States
,
Khaled A. Elmenawi
1   Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, Ohio, United States
,
Yuxuan Jin
1   Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, Ohio, United States
,
Shujaa T. Khan
1   Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, Ohio, United States
,
Cleveland Clinic Adult Reconstruction Research (CCARR),
Nicolas S. Piuzzi 
1   Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, Ohio, United States
› Author Affiliations
› Further Information
   Permissions and Reprints
Preview

Abstract

As value-based care reshapes the landscape of orthopedic surgery, understanding how insurance type influences patient-reported outcomes (PROMs) after total knee arthroplasty (TKA) is increasingly important. While Traditional Medicare (TM) and Medicare Advantage (MA) differ significantly in structure and access, limited data exist comparing functional outcomes between these groups. This retrospective cohort study used a prospectively collected institutional registry to evaluate 6,010 Medicare beneficiaries who underwent primary TKA between 2016 and 2023. Patients were categorized by insurance type (TM or MA) at the time of surgery. Primary PROMs included the KOOS pain, physical function shortform (PS), and Joint Replacement (JR) subscales. Clinically meaningful improvement was assessed using minimal clinically important difference (MCID), substantial clinical benefit (SCB), and Patient Acceptable Symptom State (PASS) thresholds. Multivariable logistic regression was performed to evaluate the independent association between insurance type and each outcome, adjusting for demographic, clinical, and socioeconomic covariates. At baseline, MA patients had significantly lower KOOS pain, PS, and JR (p < 0.001). However, by 1-year follow-up, both groups achieved similar KOOS pain and PS scores, and comparable PROM improvements from baseline. MA patients had slightly lower KOOS JR scores (p = 0.006) at 1-year, but equivalent odds of achieving MCID, PASS, and SCB thresholds across all KOOS domains after multivariable adjustment. Patient satisfaction at 1 year also did not differ by Medicare plan type (p = 0.729). Despite presenting with worse baseline functional status, MA patients achieved similar postoperative outcomes, PROM gains, and satisfaction as their TM counterparts. These findings suggest that MA enrollment does not negatively impact patient-perceived benefit after TKA and may not warrant differential risk-adjustment in PROM-based value assessments.

Keywords

arthroplasty - replacement - knee - Medicare Advantage

Note

Members of CCARR: Ignacio Pasqualini, Lakshmi S. Gudapati, Robert M. Molloy, Trevor G. Murray, Viktor E. Krebs, Peter Surace, John P. McLaughlin, Michael R. Bloomfield, Alexander Roth, Nicholas Scarcella, Michael Erossy.




Publication History

Received: 10 July 2025

Accepted: 30 August 2025

Article published online:
17 September 2025

© 2025. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Pasqualini I, Piuzzi NS. New CMS policy on the mandatory collection of patient-reported outcome measures for total hip and knee arthroplasty by 2027: what orthopaedic surgeons should know. J Bone Joint Surg Am 2024; 106 (13) 1233-1241
    CrossrefPubMedSearch in Google Scholar
  • 2 Plate JF, Deen JT, Deans CF, Pour AE, Yates AJ, Sterling RS. Implementation of the new Medicare-mandated patient-reported outcomes after joint arthroplasty performance measure. J Arthroplasty 2024; 39 (05) 1136-1139
    CrossrefPubMedSearch in Google Scholar
  • 3 Elmenawi KA, Pasqualini I, Khan ST. et al; Cleveland Clinic Adult Reconstruction Research Group. Comparing Medicare and non-Medicare inpatient total knee arthroplasty: is the new centers for Medicare and Medicaid services patient-reported outcomes performance measure mandate applicable to all?. J Arthroplasty 2025; 26: S0883 -5403(25)00600-X
    PubMedSearch in Google Scholar
  • 4 Wang JC, Piple AS, Chen XT. et al. The rise of Medicare advantage: effects on total joint arthroplasty patient care and research. J Bone Joint Surg Am 2022; 104 (24) 2145-2152
    CrossrefPubMedSearch in Google Scholar
  • 5 DeClercq MG, Keeley JH, Runner RP. et al. Associated risk of Medicaid and Medicare payer status on outcomes following total joint arthroplasty: a 10-year report. J Arthroplasty 2025; 40 (09) 2275-2284.e1
    CrossrefPubMedSearch in Google Scholar
  • 6 Yayac MF, Harrer SL, Janiec DA, Courtney PM. Costs and outcomes of Medicare advantage and traditional Medicare beneficiaries after total hip and knee arthroplasty. J Am Acad Orthop Surg 2020; 28 (20) e910-e916
    CrossrefPubMedSearch in Google Scholar
  • 7 Anderson KE, Wu RJ, Darden M, Jain A. Medicare advantage is associated with lower utilization of total joint arthroplasty. J Bone Joint Surg Am 2024; 106 (03) 198-205
    CrossrefPubMedSearch in Google Scholar
  • 8 Landon BE, Zaslavsky AM, Anderson TS, Souza J, Curto V, Ayanian JZ. Differences in use of services and quality of care in Medicare advantage and traditional Medicare, 2010 and 2017. Health Aff (Millwood) 2023; 42 (04) 459-469
    CrossrefPubMedSearch in Google Scholar
  • 9 Magnuson JA, Hobbs J, Yakkanti R, Gold PA, Courtney PM, Krueger CA. Lower revenue surplus in Medicare advantage versus private commercial insurance for total joint arthroplasty: an analysis of a single payor source at one institution. J Arthroplasty 2024; 39 (01) 26-31.e1
    CrossrefPubMedSearch in Google Scholar
  • 10 Trish E, Valdez S, Ginsburg PB, Randall S, Lieberman SM. Substantial growth in Medicare advantage and implications for reform. Health Aff (Millwood) 2023; 42 (02) 246-251
    CrossrefPubMedSearch in Google Scholar
  • 11 Xu L, Welch WP, Sheingold S, De Lew N, Sommers BD. Medicare switching: patterns of enrollment growth in Medicare advantage, 2006-22. Health Aff (Millwood) 2023; 42 (09) 1203-1211
    PubMedSearch in Google Scholar
  • 12 Meyers DJ, Belanger E, Joyce N, McHugh J, Rahman M, Mor V. Analysis of drivers of disenrollment and plan switching among Medicare advantage beneficiaries. JAMA Intern Med 2019; 179 (04) 524-532
    CrossrefPubMedSearch in Google Scholar
  • 13 Starring H, Waddell WH, Steward W. et al. Total Knee Arthroplasty Outcomes in Patients with Medicare, Medicare Advantage, and Commercial Insurance. J Knee Surg 2020; 33 (09) 919-926
    Thieme ConnectPubMedSearch in Google Scholar
  • 14 Emara AK, Pasqualini I, Jin Y. et al; the Cleveland Clinic Arthroplasty Group. Diagnosis-specific thresholds of the minimal clinically important difference and patient acceptable symptom state for KOOS after total knee arthroplasty. J Bone Joint Surg Am 2024; 106 (09) 793-800
    CrossrefPubMedSearch in Google Scholar
  • 15 Pasqualini I, Benyamini B, Khan ST, Pumo T, Piuzzi NS. Cleveland Clinic Adult Reconstruction Research Group (CCARR). Establishing diagnosis-specific measures of clinical meaningfulness for the knee injury and osteoarthritis outcome score in aseptic revision total knee arthroplasty. J Arthroplasty 2025; 40 (9S1): S338 , 343.e1
    CrossrefPubMedSearch in Google Scholar
  • 16 Curtis GL, Tariq MB, Brigati DP, Faour M, Higuera CA. Cleveland Clinic Orthopaedic Arthroplasty Group. Validation of a novel surgical data capturing system following total hip arthroplasty. J Arthroplasty 2018; 33 (11) 3479-3483
    CrossrefPubMedSearch in Google Scholar
  • 17 Cleveland OME. OME Cleveland Clinic Orthopaedics. Implementing a scientifically valid, cost-effective, and scalable data collection system at point of care: the Cleveland Clinic OME Cohort. J Bone Joint Surg Am 2019; 101 (05) 458-464
    CrossrefPubMedSearch in Google Scholar
  • 18 Emara AK, Grits D, Klika AK. et al. NarxCare scores greater than 300 are associated with adverse outcomes after primary THA. Clin Orthop Relat Res 2021; 479 (09) 1957-1967
    CrossrefPubMedSearch in Google Scholar
  • 19 Emara AK, Santana D, Grits D. et al. Exploration of overdose risk score and postoperative complications and health care use after total knee arthroplasty. JAMA Netw Open 2021; 4 (06) e2113977
    CrossrefPubMedSearch in Google Scholar
  • 20 Khan ST, Pasqualini I, Rullán PJ. et al. Predictive modeling of medical- and orthopaedic-related 90-day readmissions following primary total hip arthroplasty. J Arthroplasty 2024; 39 (11) 2812-2819.e2
    CrossrefPubMedSearch in Google Scholar
  • 21 Grits D, Emara AK, Klika AK, Murray TG, McLaughlin JP, Piuzzi NS. Neighborhood socioeconomic disadvantage associated with increased healthcare utilization after total hip arthroplasty. J Arthroplasty 2022; 37 (10) 1980-1986.e2
    CrossrefPubMedSearch in Google Scholar
  • 22 Jevnikar BE, Huffman N, Roth A. et al; CCARR Corporate Authorship. Impacts of neighborhood deprivation on septic and aseptic revision total knee arthroplasty outcomes: a comprehensive analysis using the area deprivation index. Knee 2024; 51: 74-83
    CrossrefPubMedSearch in Google Scholar
  • 23 Jevnikar BE, Huffman N, Pasqualini I. et al; CCARR Corporate Authorship. Neighborhood socioeconomic disadvantage is associated with increased health care utilization after septic and aseptic revision total hip arthroplasty. J Arthroplasty 2025; 40 (03) 550-558.e2
    CrossrefPubMedSearch in Google Scholar
  • 24 Hadad MJ, Rullán-Oliver P, Grits D. et al. Racial disparities in outcomes after THA and TKA are substantially mediated by socioeconomic disadvantage both in black and white patients. Clin Orthop Relat Res 2023; 481 (02) 254-264
    CrossrefPubMedSearch in Google Scholar
  • 25 Emara AK, Pasqualini I, Jin Y. et al; Cleveland Clinic Arthroplasty Group. What are the diagnosis-specific thresholds of minimal clinically important difference and patient acceptable symptom state in hip disability and osteoarthritis outcome score after primary total hip arthroplasty?. J Arthroplasty 2024; 39 (07) 1783-1788.e2
    CrossrefPubMedSearch in Google Scholar
  • 26 Lyman S, Lee YY, McLawhorn AS, Islam W, MacLean CH. What are the minimal and substantial improvements in the hoos and koos and jr versions after total joint replacement?. Clin Orthop Relat Res 2018; 476 (12) 2432-2441
    CrossrefPubMedSearch in Google Scholar
  • 27 Orr MN, Klika AK, Gagnier JJ, Bhandari M, Piuzzi NS. A call for a standardized approach to reporting patient-reported outcome measures: clinical relevance ratio. J Bone Joint Surg Am 2021; 103 (22) e91
    CrossrefPubMedSearch in Google Scholar
  • 28 Orr MN, Klika AK, Emara AK, Piuzzi NS. Cleveland Clinic Arthroplasty Group. Combinations of preoperative patient-reported outcome measure phenotype (pain, function, and mental health) predict outcome after total knee arthroplasty. J Arthroplasty 2022; 37 (6S): S110-S120 , 120.e5
    CrossrefPubMedSearch in Google Scholar
  • 29 Orr MN, Klika AK, Emara AK, Piuzzi NS. Cleveland Clinic Arthroplasty Group. Dissatisfaction after total hip arthroplasty associated with preoperative patient-reported outcome phenotypes. J Arthroplasty 2022; 37 (7S): S498-S509
    CrossrefPubMedSearch in Google Scholar
  • 30 Vega J, Emara AK, Orr M, Klika AK, Piuzzi NS. the Cleveland Clinic Arthroplasty Group. Demographic and socioeconomic determinants are associated with poor preoperative patient-reported pain and function in primary TKA: a cohort study of 14,079 patients. J Bone Joint Surg Am 2023; 105 (04) 286-292
    CrossrefPubMedSearch in Google Scholar
  • 31 Pasqualini I, Rullán PJ, Huffman N. et al. Challenging the status quo: debunking the necessity of 5-year to 10-year patient-reported outcome measures in total hip and knee arthroplasties. J Arthroplasty 2024; 39 (9S2): S143-S150
    CrossrefPubMedSearch in Google Scholar
  • 32 Piuzzi NS. Cleveland Clinic O. M. E. Arthroplasty Group. Patient-reported outcomes at 1 and 2 years after total hip and knee arthroplasty: what is the minimum required follow-up?. Arch Orthop Trauma Surg 2022; 142 (09) 2121-2129
    CrossrefPubMedSearch in Google Scholar